Braden McCurrach

View Braden McCurrach 's Martindale-Hubbell Connected Profile
New York,  NY  U.S.A.
Phone212 504 6788

Peer Rating

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Corporate
  • Corporate Finance
  • Corporate Governance
  • Mergers & Acquisitions
University Duke University, A.B., 2003
Law SchoolUniversity of Michigan Law School, J.D., 2006
Admitted2007, New York; U.S. District Court, Southern District of New York; U.S. District Court, Eastern District of New York

Braden McCurrach concentrates his practice in the area of corporate law, with emphasis on mergers and acquisitions, securities and corporate governance. Braden has significant experience with a wide range of transactions, including public company mergers, private acquisitions, public and private securities offerings, proxy contests and tender offers.

He received his A.B. from Duke University and his J.D. from the University of Michigan Law School. Braden is admitted to practice law in the State of New York as well as in the U.S. District Court for the Southern District of New York and the U.S. District Court for the Eastern District of New York.


Representative transactions on which Braden has worked include:

• Elan's sale of its interest in TYSABRI, a multiple sclerosis treatment, to Biogen Idec

• AngioDynamics, Inc.'s acquisition of Navilyst Medical

• Pfizer Inc.'s acquisition of Wyeth

• Celanese's sale of its polyvinyl alcohol business to Sekisui Chemical

• Bear Stearns Companies Inc. acquisition by JPMorgan Chase

• The United States Department of the Treasury in connection with its TARP investments

• The Special Committee of the Board of Directors of Landry's Restaurants, Inc. in the acquisition of Landry's Restaurants, Inc. by Tilman J. Fertitta

• Trian Fund Management, L.P. in its tender offer for shares of common stock of Wendys/Arbys Group, Inc.

• Cosi, Inc. in its rights offering to common stockholders

• Wilshire Enterprises, Inc. in its proxy contest with Full Value and subsequent self-tender offer to purchase half of Wilshire's outstanding shares

• Xstrata Plc's sale of its Noranda aluminum division to Apollo Management

• Trian Partners in its proxy contest with H.J. Heinz Company

• Charming Shoppes, Inc. in its proxy contest with Crescendo Investments

News & Resources


News Releases

•Cadwalader Named to Winner's Circle at M&A Atlas Awards
Feb 24, 2010

•Cadwalader Transaction Named IDD Deal of the Year
Feb 12, 2010

Recent Press

•New Deals - Lawyers on Major Transactions
Jan 29, 2009


Clients Friends Memos

•M&A Update: Delaware Court Upholds Sotheby's Poison Pill Defense Against Activist Citing Negative Control as a Corporate Threat
May 05, 2014

•Recent Amendments to Rule 14a-8 and the Implications for the 2012 Proxy Season
Sep 28, 2011


Documents by this lawyer on

Subscribe to this feed

M&A Update: Delaware Court Upholds Sotheby’s Poison Pill Defense Against Activist Citing “Negative Control” as a Corporate Threat
Jason M. Halper,Gregory A. Markel,Braden McCurrach,William P. Mills,Martin L. Seidel, May 7, 2014
In a May 2, 2014 ruling relating to activist hedge fund Third Point LLC’s proxy battle with auction house Sotheby’s, the Delaware Chancery Court found that Third Point was not likely to succeed in its argument that the Sotheby’s board violated its fiduciary duties when it adopted...
Profile Visibility
#10,873 in weekly profile views out of 89,433 lawyers in New York, New York
#140,963 in weekly profile views out of 1,537,162 total lawyers Overall

Office Information

Braden McCurrach

New YorkNY 10281-0006


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now